Published in Curr Opin Organ Transplant on October 01, 2008
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) | NCT00320606
Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol (2010) 2.38
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol (2011) 1.45
The liver works as a school to educate regulatory immune cells. Cell Mol Immunol (2013) 0.86
Clinical transplantation and tolerance: are we there yet? Int J Organ Transplant Med (2014) 0.79
CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection. Transpl Immunol (2015) 0.78
Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trial. Am J Transplant (2015) 0.76
Regulatory T cells: Tolerance Induction in Solid Organ Transplantation. Clin Exp Immunol (2017) 0.75
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
Reversal of transplantation immunity by liver grafting. Nature (1981) 3.07
Weaning of immunosuppression in living donor liver transplant recipients. Transplantation (2001) 2.18
Chronic rejection. Immunity (2001) 1.98
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl (2001) 1.50
Pediatric transplantation in the United States, 1997-2006. Am J Transplant (2008) 1.46
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Renal function before and long after liver transplantation in children. Transplantation (2001) 1.43
Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology (1998) 1.41
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol (2006) 1.40
An appraisal of tolerance in liver transplantation. Am J Transplant (2006) 1.32
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21
Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation (2003) 1.08
Health status ten years after pediatric liver transplantation--looking beyond the graft. Transplantation (2004) 1.05
Pediatric transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.05
Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant (2007) 1.03
Tolerance: is it worth the risk? Transplantation (2005) 1.03
The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01
Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience. Liver Transpl (2002) 1.00
Current status of liver transplantation in children. Pediatr Clin North Am (2003) 0.99
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation (2004) 0.99
Long-term survival expectancy after liver transplantation in children. J Pediatr Surg (2000) 0.96
Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg (2007) 0.94
Skin cancer in liver transplant recipients. Liver Transpl (2000) 0.94
Renal function outcome in pediatric liver transplant recipients. Pediatr Transplant (2005) 0.93
Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol (2006) 0.91
Risk factors for chronic rejection after pediatric liver transplantation. Transplantation (2001) 0.88
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant (1999) 0.85
What is the significance of acute liver allograft rejection? J Hepatol (1998) 0.84
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation (2002) 0.84
Outcomes following liver transplantation. Semin Pediatr Surg (2008) 0.83
Skin cancers following pediatric organ transplantation. Dermatol Surg (2004) 0.83
High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr (2006) 0.83
Renal outcomes in pediatric liver transplantation. Clin Transplant (1997) 0.83
Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc (2005) 0.82
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation (2007) 0.80
Complete withdrawal of immunosuppression in living donor liver transplantation. Transplant Proc (2002) 0.79
Long-term renal function in pediatric liver and heart recipients. Pediatr Transplant (2004) 0.79
Acute liver allograft rejection--is treatment always necessary? Transplantation (1993) 0.79
Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr Transplant (2004) 0.77
Selective treatment of early acute rejection after liver transplantation: effects on liver, infection rate, and outcome. Transpl Int (1997) 0.76
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc (2002) 0.76